Rhythm CSO exercises 4,445 RSUs; tax shares withheld
Rhythm Pharmaceuticals Chief Scientific Officer Alastair Garfield reported routine equity compensation activity involving restricted stock units and related tax withholding.
Rhea-AI Filing Summary
Rhythm Pharmaceuticals Chief Scientific Officer Alastair Garfield reported routine equity compensation activity involving restricted stock units and related tax withholding. On July 1, 2026, he exercised 4,445 restricted stock units, each converting into one share of common stock, increasing his direct common stock holdings to 12,208 shares.
To cover withholding taxes on this vesting, 2,150 common shares were withheld, classified as a tax-withholding disposition rather than an open-market sale. Following these transactions, Garfield also holds 8,888 restricted stock units, which vest in four equal annual installments of 25% each starting from July 1, 2024, contingent on his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
4,445 shares exercised/converted
Exercise
3 txns
Insider
Garfield Alastair
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 4,445 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,445 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,150 | $110.41 | $237K |
Holdings After Transaction:
Restricted Stock Units — 8,888 contracts (Direct);
Common Stock — 10,058 shares (Direct)
Footnotes (3)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein.
- F3. The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.
Key Figures
RSUs exercised: 4,445 units
Shares withheld for taxes: 2,150 shares
Common shares held after transactions: 12,208 shares
+3 more
6 metrics
RSUs exercised
4,445 units
Restricted stock units converted into common stock on July 1, 2026
Shares withheld for taxes
2,150 shares
Common shares withheld to cover vesting-related withholding taxes
Common shares held after transactions
12,208 shares
Direct common stock ownership following July 1, 2026 entries
RSUs outstanding
8,888 units
Remaining restricted stock units after the reported vesting and conversion
RSU-for-share ratio
1 unit : 1 share
Each restricted stock unit represents one share of common stock
Annual vesting rate
25% per year
RSUs vest in four equal installments from July 1, 2024
Key Terms
restricted stock units, tax-withholding disposition, derivative exercise/conversion, vesting
4 terms
restricted stock units financial
"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"These shares were withheld for payment of the withholding taxes upon the vesting of the restricted stock units reported herein."
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
vesting financial
"The restricted stock units vest as to 25% of the total restricted stock units on each of the first four anniversaries of July 1, 2024"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Rhythm Pharmaceuticals (RYTM) report for Alastair Garfield?
Rhythm Pharmaceuticals reported that Chief Scientific Officer Alastair Garfield exercised 4,445 restricted stock units into common stock. The transaction reflects equity compensation vesting rather than an open-market purchase or sale, and is part of his ongoing stock-based compensation package.
Were Alastair Garfield’s Rhythm Pharmaceuticals (RYTM) transactions open-market sales?
No, the Form 4 classifies 2,150 shares as a tax-withholding disposition to pay vesting-related taxes, not an open-market sale. The main action is exercising 4,445 restricted stock units into common shares as part of his compensation program.
What are the vesting terms of Alastair Garfield’s Rhythm Pharmaceuticals (RYTM) restricted stock units?
The restricted stock units vest in four equal installments of 25% each on the first four anniversaries of July 1, 2024. Vesting is conditioned on Garfield’s continued service with Rhythm Pharmaceuticals on each applicable vesting date.
How many Rhythm Pharmaceuticals (RYTM) restricted stock units does Alastair Garfield still hold after this filing?
After the July 1, 2026 transactions, Garfield holds 8,888 restricted stock units. Each unit represents a contingent right to receive one share of Rhythm Pharmaceuticals common stock, subject to the specified time-based vesting and continued service conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
